Search research articles
Contact Us
Filters
Showing results (21-30 of 128) with videos related to
Page
of 13
Sort By:
Therapeutic Advances in Medical Oncology
|
April 8, 2024
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear
Davide Melisi, Simona Casalino, Silvia Pietrobono, et al.
Biomedicines
|
May 27, 2017
Toll-Like Receptor 9 Agonists for Cancer Therapy
Davide Melisi, Melissa Frizziero, Anna Tamburrino, et al.
Cancers
|
August 27, 2021
The Multifaceted Role of TGF-β in Gastrointestinal Tumors
Fabio Sabbadini, Monica Bertolini, Serena De Matteis, et al.
International Journal of Molecular Sciences
|
October 28, 2018
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
Priscilla Cascetta, Alessandro Cavaliere, Geny Piro, et al.
International Journal of Molecular Sciences
|
February 2, 2018
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
Carmine Carbone, Geny Piro, Valeria Merz, et al.
Future Oncology (London, England)
|
March 5, 2021
Chart review of diagnostic methods, baseline characteristics and symptoms for European patients with pancreatic cancer
Alfredo Carrato, Davide Melisi, Gerald Prager, et al.
Molecular Cancer Research : MCR
|
May 14, 2009
Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB
Davide Melisi, Jiangong Niu, Zhe Chang, et al.
Expert Review of Anticancer Therapy
|
December 21, 2017
The development of PARP as a successful target for cancer therapy
Roberto Ferrara, Francesca Simionato, Chiara Ciccarese, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
October 28, 2018
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data
Giovanni Marchegiani, Stefano Andrianello, Chiara Dal Borgo, et al.
Cancers
|
May 6, 2020
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
Valeria Merz, Alessandro Cavaliere, Carlo Messina, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 128) with videos related to
Sort By:
Page
of 13
Therapeutic Advances in Medical Oncology
|
April 8, 2024
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear
Davide Melisi, Simona Casalino, Silvia Pietrobono, et al.
Biomedicines
|
May 27, 2017
Toll-Like Receptor 9 Agonists for Cancer Therapy
Davide Melisi, Melissa Frizziero, Anna Tamburrino, et al.
Cancers
|
August 27, 2021
The Multifaceted Role of TGF-β in Gastrointestinal Tumors
Fabio Sabbadini, Monica Bertolini, Serena De Matteis, et al.
International Journal of Molecular Sciences
|
October 28, 2018
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
Priscilla Cascetta, Alessandro Cavaliere, Geny Piro, et al.
International Journal of Molecular Sciences
|
February 2, 2018
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
Carmine Carbone, Geny Piro, Valeria Merz, et al.
Future Oncology (London, England)
|
March 5, 2021
Chart review of diagnostic methods, baseline characteristics and symptoms for European patients with pancreatic cancer
Alfredo Carrato, Davide Melisi, Gerald Prager, et al.
Molecular Cancer Research : MCR
|
May 14, 2009
Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB
Davide Melisi, Jiangong Niu, Zhe Chang, et al.
Expert Review of Anticancer Therapy
|
December 21, 2017
The development of PARP as a successful target for cancer therapy
Roberto Ferrara, Francesca Simionato, Chiara Ciccarese, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
October 28, 2018
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data
Giovanni Marchegiani, Stefano Andrianello, Chiara Dal Borgo, et al.
Cancers
|
May 6, 2020
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
Valeria Merz, Alessandro Cavaliere, Carlo Messina, et al.
Page
of 13